AE-941

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameAE-941
Drug Alias NamePsovascarNeovastatNeoretnaArthrovasNSC-706456 +[6] 
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMatrix metalloproteinase 9 inhibitorsMatrix metalloproteinase-2 inhibitorsVascular endothelial growth factor receptor 2 antagonists +[4] 
TargetsMatrix metalloproteinase 12Matrix metalloproteinase 9Vascular endothelial growth factor receptor 2 +[4] 
Therapy Area/IndicationsKidney NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCOSCIENS Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteCOSCIENS Biopharma Inc
Active IndicationsN/A
Inactive IndicationsKidney NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A